-
Febuxostat CAS144060-53-7Approved description: a used in the treatment of high uric acid hematic disease and chronic gout of xanthine oxidase inhibitors.
-
Magnesium dihydrogen di-L-aspartate CAS2068-80-6Used as a preservative raw materials, pharmaceutical raw materials, feed additives